# A Pilot Study of RNS60 in Amyotrophic Lateral Sclerosis (ALS)

> **NCT02525471** · PHASE1 · COMPLETED · sponsor: **Sabrina Paganoni, M.D.** · enrollment: 24 (actual)

## Conditions studied

- ALS

## Interventions

- **DRUG:** RNS60

## Key facts

- **NCT ID:** NCT02525471
- **Lead sponsor:** Sabrina Paganoni, M.D.
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10
- **Primary completion:** 2017-06-21
- **Final completion:** 2017-10-18
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2021-05-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02525471

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02525471, "A Pilot Study of RNS60 in Amyotrophic Lateral Sclerosis (ALS)". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02525471. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*